Pazopanib Impurity 29 | CAS 1296888-46-4 - Request Quote
Pazopanib Impurity 29
| SZ CAT No: | SZ-P013043 |
| CAS No | 1296888-46-4 |
| Mol.F. | C16H20N6 |
| Mol.Wt. | 296.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pazopanib Impurity 29 is chemically N4-(2,3-dimethyl-2H-indazol-6-yl)-N2,N2,N4-trimethylpyrimidine-2,4-diamine. Pazopanib Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Pazopanib Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pazopanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1296888-46-4
Purchase 1296888-46-4
Order 1296888-46-4
Enquire 1296888-46-4
price of 1296888-46-4
1296888-46-4 Supplier
1296888-46-4 Manufacturer
1296888-46-4 Exporter
buy high quality Pazopanib Impurity 29
Purchase Pazopanib Impurity 29
Pazopanib Impurity 29 suppliers
Pazopanib Impurity 29 manufacturers
Pazopanib Impurity 29 price
Order Pazopanib Impurity 29
Enquire Pazopanib Impurity 29
Pazopanib Impurity 29 cost
Pazopanib Impurity 29 Supplier
Pazopanib Impurity 29 Distributor
Pazopanib Impurity 29 for Method Validation
Pazopanib Reference Standard
Pazopanib Impurity 29 for ANDA Filing
Pazopanib Impurity 29 for Forced Degradation Studies
Pazopanib Impurity 29 Identification Standards
Pazopanib Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


